Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib
Haruki Uojima(National Center for Global Health and Medicine), Wasaburo Koizumi(Kitasato University), Katsuaki Ogushi(Yokohama City University Medical Center), Makoto Chuma(Yokohama City University Medical Center), Nobuhiro Hattori(St. Marianna University School of Medicine), Satoshi Kobayashi(Kanagawa Cancer Center), Makoto Kako(Shonan Kamakura General Hospital), Takahide Nakazawa(Kitasato University Hospital), Tatehiro Kagawa(Tokai University), Katsuaki Tanaka(Yokohama City University Medical Center), Manabu Morimoto(Kanagawa Prefectural Hospital Organization), Hisashi Hidaka(Kitasato University), Shogo Iwabuchi(Jikei University School of Medicine), Yoshiaki Tanaka(Jichi Medical University)
Cited by 91
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513